EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bavarian Nordic AS's enterprise value is $1,876.3 Mil.
Bavarian Nordic AS's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $898.0 Mil. Therefore, Bavarian Nordic AS's EV-to-Revenue for today is 2.09.
The historical rank and industry rank for Bavarian Nordic AS's EV-to-Revenue or its related term are showing as below:
BVNKF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.37 Med: 5.32 Max: 14.39
Current: 2.09
During the past 13 years, the highest EV-to-Revenue of Bavarian Nordic AS was 14.39. The lowest was 1.37. And the median was 5.32.
BVNKF's EV-to-Revenue is ranked better than 77.63% of 997
companies
in the Biotechnology industry
Industry Median: 7.47
vs BVNKF: 2.09
The historical data trend for Bavarian Nordic AS's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bavarian Nordic AS's EV-to-Revenue
For the Biotechnology subindustry, Bavarian Nordic AS's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bavarian Nordic AS's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Bavarian Nordic AS's EV-to-Revenue falls into.
Bavarian Nordic AS's current Enterprise Value is $1,876.3 Mil.
Bavarian Nordic AS's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $898.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bavarian Nordic AS (OTCPK:BVNKF) EV-to-Revenue Explanation
Bavarian Nordic AS's share price for today is $26.20.
Bavarian Nordic AS's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bavarian Nordic AS EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Bavarian Nordic AS's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BVNKF has been successfully added to your 